March 20 (Reuters) - FDA:
FDA: AWARE BARD PERIPHERAL VASCULAR ISSUED LETTER TO AFFECTED CUSTOMERS PROVIDING UPDATED INSTRUCTIONS FOR USE FOR ROTAREX ATHERECTOMY SYSTEMS
FDA: IDENTIFIED BARD PERIPHERAL VASCULAR'S ATHERECTOMY CATHETER SYSTEM RECALL AS THE MOST SERIOUS TYPE
FDA: BD REPORTED 30 SERIOUS INJURIES, 4 DEATHS ASSOCIATED WITH ATHERECTOMY CATHETER SYSTEM ISSUE FROM BARD PERIPHERAL VASCULAR
FDA: BD REPORTED 115 CASES REQUIRING ADDITIONAL INTERVENTION FOLLOWING HELIX FRACTURE AND/OR BREAKAGE RELATED TO ATHERECTOMY CATHETER SYSTEM ISSUE
(((( Reuters.Briefs@thomsonreuters.com ;));))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.